152 related articles for article (PubMed ID: 2088034)
1. Radiant heat systemic hyperthermia clinical trials.
Robins HI; Cohen JD
Adv Exp Med Biol; 1990; 267():189-96. PubMed ID: 2088034
[TBL] [Abstract][Full Text] [Related]
2. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.
Hildebrandt B; Hegewisch-Becker S; Kerner T; Nierhaus A; Bakhshandeh-Bath A; Janni W; Zumschlinge R; Sommer H; Riess H; Wust P;
Int J Hyperthermia; 2005 Mar; 21(2):169-83. PubMed ID: 15764358
[TBL] [Abstract][Full Text] [Related]
3. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies.
Lassche G; Crezee J; Van Herpen CML
Crit Rev Oncol Hematol; 2019 Jul; 139():67-74. PubMed ID: 31112883
[TBL] [Abstract][Full Text] [Related]
4. Temperature distribution during radiant heat whole-body hyperthermia: experimental studies in the dog.
Hugander A; Robins HI; Martin P; Schmitt C
Int J Hyperthermia; 1987; 3(3):199-208. PubMed ID: 3655435
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI; Rushing D; Kutz M; Tutsch KD; Tiggelaar CL; Paul D; Spriggs D; Kraemer C; Gillis W; Feierabend C; Arzoomanian RZ; Longo W; Alberti D; d'Oleire F; Qu RP; Wilding G; Stewart JA
J Clin Oncol; 1997 Jan; 15(1):158-64. PubMed ID: 8996137
[TBL] [Abstract][Full Text] [Related]
6. A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.
Robins HI; Dennis WH; Neville AJ; Shecterle LM; Martin PA; Grossman J; Davis TE; Neville SR; Gillis WK; Rusy BF
Cancer Res; 1985 Aug; 45(8):3937-44. PubMed ID: 4016761
[TBL] [Abstract][Full Text] [Related]
7. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia.
von Ardenne M
Strahlenther Onkol; 1994 Oct; 170(10):581-9. PubMed ID: 7974169
[TBL] [Abstract][Full Text] [Related]
8. Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status.
Wiedemann GJ; Robins HI; Katschinski DM; Mentzel M; D'Oleire F; Kutz M; Wagner T
Anticancer Res; 1997; 17(4B):2899-902. PubMed ID: 9329558
[TBL] [Abstract][Full Text] [Related]
9. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences.
Wehner H; von Ardenne A; Kaltofen S
Int J Hyperthermia; 2001; 17(1):19-30. PubMed ID: 11212877
[TBL] [Abstract][Full Text] [Related]
10. Whole body hyperthermia in the treatment of neoplastic disease.
Robins HI; Hugander A; Cohen JD
Radiol Clin North Am; 1989 May; 27(3):603-10. PubMed ID: 2648462
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy in combination with whole-body hyperthermia in advanced malignant pleural mesothelioma].
Bakhshandeh A; Bruns I; Eberhardt K; Wiedemann GJ
Dtsch Med Wochenschr; 2000 Mar; 125(11):317-9. PubMed ID: 10761473
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer.
Richel O; Zum Vörde Sive Vörding PJ; Rietbroek R; Van der Velden J; Van Dijk JD; Schilthuis MS; Westermann AM
Gynecol Oncol; 2004 Dec; 95(3):680-5. PubMed ID: 15581981
[TBL] [Abstract][Full Text] [Related]
13. Whole body hyperthermia (41-42 degrees C): a simple technique for unanesthetized mice.
Robins HI; Steeves RA; Shecterle LM; Martin PA; Miller KA; Paliwal B; Neville AJ; Dennis WH
Med Phys; 1984; 11(6):833-9. PubMed ID: 6392846
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI; Cohen JD; Schmitt CL; Tutsch KD; Feierabend C; Arzoomanian RZ; Alberti D; d'Oleire F; Longo W; Heiss C
J Clin Oncol; 1993 Sep; 11(9):1787-94. PubMed ID: 8355046
[TBL] [Abstract][Full Text] [Related]
15. The cellular and molecular basis of hyperthermia.
Hildebrandt B; Wust P; Ahlers O; Dieing A; Sreenivasa G; Kerner T; Felix R; Riess H
Crit Rev Oncol Hematol; 2002 Jul; 43(1):33-56. PubMed ID: 12098606
[TBL] [Abstract][Full Text] [Related]
16. Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients.
Storm FK; Baker HW; Scanlon EF; Plenk HP; Meadows PM; Cohen SC; Olson CE; Thomson JW; Khandekar JD; Roe D
Cancer; 1985 Jun; 55(11):2677-87. PubMed ID: 3888369
[TBL] [Abstract][Full Text] [Related]
17. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.
Hegewisch-Becker S; Braun K; Otte M; Corovic A; Atanackovic D; Nierhaus A; Hossfeld DK; Pantel K
Clin Cancer Res; 2003 Jun; 9(6):2079-84. PubMed ID: 12796371
[TBL] [Abstract][Full Text] [Related]
18. Multiple organ dysfunction syndrome induced by whole-body hyperthermia and polychemotherapy in a patient with disseminated leiomyosarcoma of the uterus.
Pereira Arias AM; Wester JP; Blankendaal M; Schilthuis MS; Kuijper EJ; Rademaker BM; Stoutenbeek CP; Rietbroek RC
Intensive Care Med; 1999 Sep; 25(9):1013-6. PubMed ID: 10501762
[TBL] [Abstract][Full Text] [Related]
19. Changes in hepatic blood flow during whole body hyperthermia.
Deja M; Ahlers O; Macguill M; Wust P; Hildebrandt B; Riess H; Kerner T
Int J Hyperthermia; 2010; 26(2):95-100. PubMed ID: 20146563
[TBL] [Abstract][Full Text] [Related]
20. Preclinical trial of a radiant heat device for whole-body hyperthermia using a porcine model.
Robins HI; Grossman J; Davis TE; AuBuchon JP; Dennis W
Cancer Res; 1983 May; 43(5):2018-22. PubMed ID: 6831432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
